Amendment #167 to H4617

DOI Rate Approval Process

Mr. McMurtry of Dedham moves to amend the bill in section 78, by striking out the last paragraph and inserting in place thereof the following paragraph:-

If the commissioner finds that the payment rate under its review is influenced by unwarranted factors of price variation as outlined in this section, the commissioner shall confidentially refer the relevant health care entities to the health policy commission to file performance improvement plans, as established in section 10A of chapter 6D.  No such finding by the commissioner shall be made without consultation with the center for health information analysis and unless substantiated by information submitted to the center for health information analysis under sections 8, 9 and 10 of chapter 12C.

and in section 80, by inserting, in line 1858, after the word “shall” the following word:- confidentially

and in section 80, by inserting, in line 1859, after the words “chapter 6D.” the following words:-

No such finding by the commissioner shall be made without consultation with the center for health information analysis and unless substantiated by information submitted to the center for health information analysis under sections 8, 9 and 10 of chapter 12C.

And in section 83, by striking out the last paragraph and inserting in place thereof the following paragraph:-

If the commissioner finds that the payment rate under its review is influenced by unwarranted factors of price variation, the commissioner shall confidentially refer the relevant health care entities to the health policy commission to file performance improvement plans, as established in section 10A of chapter 6D.  No such finding by the commissioner shall be made without consultation with the center for health information analysis and unless substantiated by information submitted to the center for health information analysis under sections 8, 9 and 10 of chapter 12C.

And in section 87, by striking out the last paragraph and inserting in place thereof the following paragraph:-

If the commissioner finds that the payment rate under its review is influenced by unwarranted factors of price variation, the commissioner shall confidentially refer the relevant health care entities to the health policy commission to file performance improvement plans, as established in section 10A of chapter 6D.  No such finding by the commissioner shall be made without consultation with the center for health information analysis and unless substantiated by information submitted to the center for health information analysis under sections 8, 9 and 10 of chapter 12C.